Nanomaterials in Alzheimer's disease treatment: a comprehensive review

M Faiyaz, MA Ganayee, S Akhtar… - Frontiers in …, 2021 - research.aalto.fi
Alzheimer's, a progressive neurodegenerative disease affects brain and neurons through
enormous reduction in nerve cell regenerative capacity. Dementia and impairment of …

Development and in vitro evaluation of donepezil hydrochloride-loaded thermo-responsive polymer grafted molybdenum disulfide nanosheets: Modeling using …

ER Soltani, HA Panahi, E Moniri, Z Yousefipour… - Colloids and Surfaces B …, 2023 - Elsevier
Nanocarriers are utilized to deliver bioactive substances in the treatment of
neurodegenerative diseases such as Alzheimer's. In this work, we prepared donepezil …

Nanomedicine in the treatment of Alzheimer's disease: bypassing the blood-brain barrier with cutting-edge nanotechnology

N Dong, P Ali-Khiavi, N Ghavamikia, SA Pakmehr… - Neurological …, 2024 - Springer
Alzheimer's disease (AD) remains a formidable challenge in the field of neurodegenerative
disorders, necessitating innovative therapeutic strategies. Nanomedicine, leveraging …

Preparation and in vitro characterization of memantine HCl loaded PLGA nanoparticles for Alzheimer's disease

G Tezel, S Ulutürk, T Reçber, SS Timur… - Journal of Drug Delivery …, 2024 - Elsevier
Alzheimer's disease (AD) is a form of dementia characterized by neuronal damage and the
buildup of abnormal proteins such as beta-amyloid and phosphorylated tau. PLGA (Poly …

Antioxidant and Antiangiogenic Effect of Homoleptic Palladium (II) Carboxamide Complex Loaded Chitosan Modified PLGA Nanoparticles: In vitro Evaluation and In …

AA Öztürk, H Ünver, HT Kıyan - Letters in Drug Design & …, 2023 - benthamdirect.com
Background: Angiogenesis is a natural and complex mechanism that is regulated by
biomolecules formed by the body. Medicinal inorganic chemistry is increasing in popularity …

Curcumin‐Encapsulated Poly(lactic‐co‐glycolic acid) Nanoparticles: A Comparison of Drug Release Kinetics from Particles Prepared via Electrospray and …

Z Roshan, V Haddadi‐Asl, H Ahmadi… - Macromolecular …, 2024 - Wiley Online Library
Controlled drug release (CDR) is a significant field of research in medical sciences due to its
numerous clinical advantages over traditional methods. Encapsulation of a drug in a …

[PDF][PDF] Encapsulation of alendronate in chitosan based polymeric nanoparticles for effective management of osteoporosis–development to release kinetic study

S Pathak, SK Tripathi, C Pachouri… - Int J Med Nano Res, 2022 - researchgate.net
Osteoporosis means" Porous bone” is a disease characterized by progressive bone
thinning. The deterioration of bone tissue can lead to bone fragility and fracture, especially of …

[PDF][PDF] Development, characterization and in vitro release kinetic studies of Ibandronate loaded chitosan nanoparticles for effective management of osteoporosis

S Pathak, SP Vyas, A Pandey - drugs, 2021 - academia.edu
Objective: The objective of the present study was to develop, optimize, and evaluate
Ibandronate-sodium loaded chitosan nanoparticles (Ib-CS NPs) to treat osteoporosis …

Targeted Nano-based Drug Delivery in Alzheimer's Disease and Dementia

P Mal, SK Rath, T Halder - … for Drug Delivery and Neurological Diseases …, 2024 - Springer
Abstract Alzheimer's disease (AD), the utmost widespread neurodegenerative illness,
contributes to an enormous and expanding healthcare burden and impairs cognitive …

PRIMAQUINE PHOSPHATE-LOADED CHITOSAN NANOPARTICLES: FORMULATION OPTIMISATION TO in vitro DRUG RELEASE KINETICS STUDY.

B PATEL, SK TRIPATHI, C PACHOURI… - Oxidation …, 2021 - search.ebscohost.com
Primaquine phosphate-loaded chitosan nanoparticles were prepared using the modified
ionic gelation method. Chitosan is a naturally occurring biopolymer that can be easily …